Skip to main content
. 2020 Aug 31;137(5):637–645. doi: 10.1182/blood.2019004753

Figure 4.

Figure 4.

Outcomes by gene signatures. (A) PFS per IRC by TLR5, C3AR1, and FCGR1A expression. (B) Best objective response per investigator by TLR5, C3AR1, and GCGR1A score. (C) Best objective response by IR-2 complete signature score. PD, progressive disease.